日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD4(+) T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

CD4(+) T 细胞介导 BCMA CAR-T 细胞治疗后 CAR-T 细胞相关的免疫相关不良事件。

Ho Matthew, Paruzzo Luca, Noll Julia Han, Stella Federico, Devi Pooja, Ndeupen Sonia, Day Yael A, Chen Gregory M, Cohen Ivan J, Ramirez-Fernandez Angel, Waxman Adam, Kapur Shivani, Chen Fang, Xu Rong, Huff Andrew, Jarocha Danuta, Patel Vrutti, Bochi-Layec Audrey C, Ramasubramanian Ranjani, Liu Shan, Bouvier Riemke, de Souza Vitor B, Patel Heta, Li Ziyu, Carturan Alberto, Michener Peter, Hopkins Caitlin R, Koucky Owen, Minehart Janna, Dimitri Alex, Nabar Neel R, Hasanali Zainul S, Ciccarelli Bryan T, Hung Putzer, Williams Erik, Bartoszek Robert, Lavorando Maya, Mohan Suyash, Gonzalez Vanessa E, Porazzi Patrizia, Bhoj Vijay G, Apostolidis Sokratis A, Vogl Dan T, Porter David L, Scholler John, Diorio Caroline, Roche Aoife M, Everett John K, Bushman Frederic D, Nathanson Katherine L, Stadtmauer Edward A, Susanibar-Adaniya Sandra P, Garfall Alfred L, Ruella Marco, Cohen Adam D, Fraietta Joseph A

Outcomes of radiation integrated with T-cell-engaging bispecific antibodies in relapsed/refractory multiple myeloma

放射治疗联合T细胞结合双特异性抗体治疗复发/难治性多发性骨髓瘤的疗效

Patel, Heta; Hubbeling, Harper; Yu, Kyle; Carpenter, Maribel; LaRiviere, Michael J; Plastaras, John P; Cohen, Adam D; Kapur, Shivani; Vogl, Dan T; Waxman, Adam J; Stadtmauer, Edward A; Garfall, Alfred L; Susanibar-Adaniya, Sandra

Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myeloma

使用莫达卡福司α进行靶向干扰素治疗复发或难治性多发性骨髓瘤

Vogl, Dan T; Atrash, Shebli; Holstein, Sarah A; Nadeem, Omar; Benson, Don; Chaudry, Maria; Biran, Noa; Suryanarayan, Kaveri; Li, Cheryl; Liu, Yuyin; Collins, Sabrina; Parot, Xavier; Kaufman, Jonathan L

A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma

一项针对复发/难治性多发性骨髓瘤患者的莫达卡福斯普α单药治疗的II期随机研究

Holstein, Sarah A; Atrash, Shebli; Mian, Hira; Dimopoulos, Meletios A; Schjesvold, Fredrik; Popat, Rakesh; Shah, Nishi; Gatt, Moshe E; Gocke, Christian B; Frenzel, Laurent; Touzeau, Cyrille; Beksac, Meral; Manier, Salomon; Magen, Hila; Travis, Patrick; Nadeem, Omar; Suryanarayan, Kaveri; Li, Cheryl; Li, Shuli; Nelson, Allison; Cherepanov, Dasha; Parot, Xavier; Vogl, Dan T

Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702

尿液无反应标准预测多发性骨髓瘤的无进展生存期:BMT CTN 0702 的事后分析

Banerjee, Rahul; Fritz, Amber R; Akhtar, Othman S; Freeman, Ciara L; Cowan, Andrew J; Shah, Nina; Landau, Heather J; Kumar, Shaji K; Vogl, Dan T; Efebera, Yvonne A; McCarthy, Philip L; Vesole, David H; Mendizabal, Adam; Krishnan, Amrita Y; Somlo, George; Stadtmauer, Edward A; Pasquini, Marcelo C

Outcomes of relapse after teclistamab therapy in multiple myeloma

多发性骨髓瘤患者接受teclistamab治疗后复发的结局

Yu, Kyle L; Ho, Matthew; Paruzzo, Luca; Stella, Federico; Patel, Heta; Hasanali, Zainul S; Kapur, Shivani; Waxman, Adam J; Vogl, Dan T; Stadtmauer, Edward A; Fraietta, Joseph A; Ruella, Marco; Cohen, Adam D; Garfall, Alfred L; Susanibar-Adaniya, Sandra

A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death-Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma

PT-112(一种新型免疫原性细胞死亡诱导小分子)治疗复发或难治性多发性骨髓瘤的 I 期临床研究及体内研究结果

Kourelis, Taxiarchis; Ailawadhi, Sikander; Vogl, Dan T; Gibson, Sarah E; Sharik, Meaghen E; Du, Megan T; Ames, Tyler D; Yim, Christina Y; Baeck, Johan; Price, Matthew R; Jimeno, Jose M; Chesi, Marta; Bergsagel, P Leif

Non-tuberculous mycobacterial infections following teclistamab in multiple myeloma

多发性骨髓瘤患者接受teclistamab治疗后发生非结核分枝杆菌感染

Ho, Matthew; Paruzzo, Luca; Minehart, Janna; Voruganti, Teja; Devi, Pooja; Vogl, Dan T; Cohen, Adam D; Garfall, Alfred L; Waxman, Adam J; Kapur, Shivani; Stadtmauer, Edward A; Adaniya, Sandra Susanibar; Longworth, Sarah

Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis

特克利司他单抗治疗复发或难治性AL淀粉样变性患者的安全性和有效性

Stalker, Margaret; Garfall, Alfred; Cohen, Adam; Vogl, Dan T; Djulbegovic, Mia; Susanibar-Adaniya, Sandra; Stadtmauer, Edward; Megherea, Oxana; Waxman, Adam J

Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival

自体造血干细胞移植和来那度胺维持治疗1年后多发性骨髓瘤的微小残留病灶状态与长期总生存期相关

Pasquini, Marcelo C; Wallace, Paul K; Logan, Brent; Kaur, Manmeet; Tario, Joseph D; Howard, Alan; Zhang, Yali; Brunstein, Claudio; Efebera, Yvonne; Geller, Nancy; Giralt, Sergio; Hari, Parameswaran; Horowitz, Mary M; Koreth, John; Krishnan, Amrita; Landau, Heather; Somlo, George; Shah, Nina; Stadtmauer, Edward; Vogl, Dan T; Vesole, David H; McCarthy, Philip L; Hahn, Theresa